ZLAB analyst estimates
Zai Lab (ZLAB) analyst ratings, the average price target and its range, and every firm's latest call.
ZLAB analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Jan 7, 2026 | UBS | Zai Lab initiated with a Buy at UBS | $35.00 |
| Jun 30, 2025 | Leerink Partners | Zai Lab price target raised to $75 from $73 at Leerink | $75.00 |
| Mar 7, 2025 | Scotiabank | Zai Lab initiated with an Outperform at Scotiabank | $55.00 |
| Sep 27, 2024 | Morgan Stanley | Morgan Stanley on Zai Lab (ZLAB) Post BMY (BMY) Approval: 'We believe it should bode moderately positively for ZLAB shares' | $50.00 |
| Apr 21, 2022 | Leerink Partners | SVB Leerink Maintains Outperform on Zai Lab, Lowers Price Target to $101 | $101.00 |
- 0 firms rate ZLAB: 0 buy, 0 hold, 0 sell.
Updated 2026-11-03 11:30 UTC